StockData

Cartesian Therapeutics, Inc. (RNAC) stock

RNACNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 1/30
$6.12+0.04 (+0.66%)

Close on Nov 17, 2026Market cap $185.16MP/E –Yield –

Cartesian Therapeutics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Cartesian Therapeutics's pe ratio was 5.1× on Apr 28, 2023.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2023Apr 28, 20235.1×+1.0
2022Dec 30, 20224.1×–

More Cartesian Therapeutics figures

See a number that looks wrong?